CooperSurgical
VC Fund
Trumbull, United States
CooperSurgical is a VC fund in Trumbull focused on Medical and Health Care. CooperSurgical offers a full portfolio of medical and surgical products and brands for women's health care that ob/gyns and other clinician.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries CooperSurgical invests in
Stages CooperSurgical invests in
Countries CooperSurgical invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Doug Oberly
|
|||
Kerry Blair
|
|||
Lisa Fawcett
|
|||
Holly Sheffield
|
|||
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Machine Learning 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Doug Oberly
Senior Director Regulatory, Special Projects
|
Senior Director Regulatory, Special Projects | Total investments: 0 | Find email | |
|
Kerry Blair
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email | |
|
Lisa Fawcett
Executive Vice President, Strategy & Market Development
|
Executive Vice President, Strategy & Market Development | Total investments: 0 | Find email | |
|
Holly Sheffield
Founder & President
|
Founder & President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Granata Bio
|
Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | $15M / Series A / Jan 15, 2025 | |
|
Granata Bio
|
Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | $14M / Series A / Jan 16, 2024 | |
DotLab
|
Women's health diagnostics using novel biomarkers and machine learning | Series A / Jul 01, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CooperSurgical invest in?
CooperSurgical invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CooperSurgical?
Public channels for CooperSurgical include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CooperSurgical?
The team at CooperSurgical includes Doug Oberly (Senior Director Regulatory, Special Projects), Kerry Blair (Chief Operating Officer) and Lisa Fawcett (Executive Vice President, Strategy & Market Development). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
